Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines

Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines

Background: Meningococcal disease (MD) is a major cause of meningitis and sepsis worldwide, with a high case fatality rate and frequent sequelae. Neisseria meningitidis serogroups A, B, C, W, X and Y are responsible for most of these life-threatening infections, and its unpredictable epidemiology ca...

Full description

Bibliographic Details
Main Authors: Rodolfo Villena, Marco Aurelio P. Safadi, María Teresa Valenzuela, Juan P. Torres, Adam Finn, Miguel O'Ryan
Format: Article
Language:English
Published: Taylor & Francis Group 2018-05-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
neisseria meningitidis
epidemiology
meningococcal serogroup b
meningococcal vaccines
outbreaks
Online Access:http://dx.doi.org/10.1080/21645515.2018.1458175

Internet

http://dx.doi.org/10.1080/21645515.2018.1458175

Similar Items